These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25744617)

  • 41. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
    Sebastiani G; Alshaalan R; Wong P; Rubino M; Salman A; Metrakos P; Deschenes M; Ghali P
    PLoS One; 2015; 10(6):e0128774. PubMed ID: 26083565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency.
    Takahashi Y; Iida K; Takahashi K; Yoshioka S; Fukuoka H; Takeno R; Imanaka M; Nishizawa H; Takahashi M; Seo Y; Hayashi Y; Kondo T; Okimura Y; Kaji H; Kitazawa R; Kitazawa S; Chihara K
    Gastroenterology; 2007 Mar; 132(3):938-43. PubMed ID: 17324404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
    Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant program.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Gunetilleke B; de Silva HJ
    Indian J Gastroenterol; 2016 May; 35(3):222-4. PubMed ID: 27142096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Case of Hypopituitarism Complicated by Non-Alcoholic Steatohepatitis and Severe Pulmonary Hypertension.
    Suzuki K; Kanamoto M; Hinohara H; Saito S
    Am J Case Rep; 2021 Jan; 22():e928004. PubMed ID: 33395403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
    Ahmed A; Wong RJ; Harrison SA
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2062-70. PubMed ID: 26226097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perspectives on Treatment for Nonalcoholic Steatohepatitis.
    Lassailly G; Caiazzo R; Pattou F; Mathurin P
    Gastroenterology; 2016 Jun; 150(8):1835-48. PubMed ID: 26971824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India.
    Kumar S; Khandelwal N; Kumar A; Yadav K; Sharma S; Sable S; Chauhan A; Kapoor S; Varma V; Palep J; Kumaran V
    Indian J Gastroenterol; 2017 May; 36(3):243-247. PubMed ID: 28560633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis.
    Wang X; Li J; Riaz DR; Shi G; Liu C; Dai Y
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):394-402.e1. PubMed ID: 24076414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data.
    Wong RJ; Chou C; Bonham CA; Concepcion W; Esquivel CO; Ahmed A
    Clin Transplant; 2014 Jun; 28(6):713-21. PubMed ID: 24654688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of Recurrent NASH-Related Allograft Cirrhosis.
    Kakar S; Dugum M; Cabello R; Humar A; Ahmad J; Malik SM
    Dig Dis Sci; 2019 May; 64(5):1356-1363. PubMed ID: 30560336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Living donor liver transplantation for Dorfman-Chanarin syndrome with 1 year follow-up: case report.
    Takeda K; Tanaka K; Kumamoto T; Morioka D; Endo I; Togo S; Shimada H
    Transplant Proc; 2010 Nov; 42(9):3858-61. PubMed ID: 21094870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis.
    Koh H; Kim S; Kim MJ; Kim HG; Shin HJ; Lee MJ
    World J Gastroenterol; 2015 Sep; 21(33):9741-8. PubMed ID: 26361421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.